Status:
UNKNOWN
Oncodrivers in Malignant Pleural Effusions Associated With Non-small Cell Lung Cancer: A Prospective Study.
Lead Sponsor:
Naestved Hospital
Conditions:
Malignant Pleural Effusion
Non-small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Oncological treatment of patients with disseminated non-small cell lung cancer (NSCLC) is depending on the status of programmed death-ligand 1 (PD-L1), anaplastic lymphoma kinase (ALK) and epidermal g...
Detailed Description
The study is a prospective, non-randomized, cohort study of patients with pleural effusion. Participants will be recruited from patients referred to the Pleura Clinic or admitted at the ward at the De...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Pleural effusion known or suspected of association with NSCLC (pleural fluid cytology positive for cells from NSCLC)
- Patients must be able to give informed consent
Exclusion
- Full oncodriver status measured in any pleural fluid in current work-up
- Inability to understand written or spoken Danish.
Key Trial Info
Start Date :
March 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 12 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04806412
Start Date
March 15 2021
End Date
May 12 2023
Last Update
May 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Næstved Sygehus, department of pulmonary medicine
Næstved, Region Sjælland, Denmark, 4700